MicroRNAs in renal fibrosis

Area of Science:

• Molecular biology
• Nephrology
• Biochemistry

Background:

• MicroRNAs (miRNAs) are endogenous short non-coding RNAs regulating gene expression post-transcriptionally.
• miRNAs are implicated in renal development, homeostasis, and the pathogenesis of kidney diseases.
• Chronic kidney disease (CKD) involves renal fibrosis, a process mediated by transforming growth factor beta (TGF-β).

Purpose of the Study:

• To explore the intricate relationship between TGF-β signaling and miRNA expression in renal diseases.
• To elucidate the specific roles of miRNAs in the initiation and progression of renal fibrosis.
• To highlight the potential of miRNAs as early biomarkers and therapeutic targets for kidney diseases.

Main Methods:

• Review of clinical and experimental animal studies.
• Analysis of miRNA expression patterns in response to TGF-β signaling.
• Investigation of miRNA-mediated mechanisms in renal fibrosis and epithelial-to-mesenchymal transition.

Main Results:

• TGF-β signaling influences the expression of specific miRNAs, including miR-21, miR-192, miR-200, miR-433, and miR-29.
• Certain miRNAs (miR-21, miR-192, miR-433) are upregulated by TGF-β and contribute to kidney pathology.
• Other miRNAs (miR-29, miR-200 families) are inhibited by TGF-β and offer protection against renal fibrosis.

Conclusions:

• miRNAs play dual roles in renal fibrosis, with some promoting and others inhibiting the process.
• miRNAs in circulation show promise as early diagnostic biomarkers for renal diseases.
• Targeting specific miRNAs presents a potential therapeutic avenue for managing kidney diseases and renal fibrosis.